Product Information
DICLOFENAC POTASSIUM 25 MG CAP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.8071 per EA under NDC 00480943589. Its NADAC has been published 181 times since Dec 21, 2022.
FDA first approved this application on Feb 23, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480943589
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA204648FDA Approved
2/23/2016
TE Code
AB
On Market Since
3/24/2022
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC POTASSIUM 25 MG CAP has been published 181 times since Dec 21, 2022, and over the history we have for it it has declined 64.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8071 per EA |
|---|---|
| All-time high | $7.8865 (Dec 13, 2023) |
| All-time low | $2.1109 (Jul 23, 2025) |
| 52-week high | $3.3863 |
| 52-week low | $2.2747 |
| Median price | $3.6322 |
| Average price | $4.8185 |
| Largest weekly change | -29.0% (Aug 21, 2024) |
| Weeks tracked | 181 |
| Tracking since | Dec 21, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diclofenac potassium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICLOFENAC POTASSIUM 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC POTASSIUM 25 MG CAP, manufactured by Teva Pharmaceuticals USA Inc., is $2.8071 per EA (NDC 00480943589), effective Sep 30, 2026.
How has the price of DICLOFENAC POTASSIUM 25 MG CAP changed over time?
Over the history we have for it, the NADAC for DICLOFENAC POTASSIUM 25 MG CAP has declined 64.4%. It has been tracked across 181 weekly CMS publications since Dec 21, 2022.
What are the highest and lowest recorded NADAC prices for DICLOFENAC POTASSIUM 25 MG CAP?
Since Dec 21, 2022, the NADAC for DICLOFENAC POTASSIUM 25 MG CAP has ranged from a low of $2.1109 (Jul 23, 2025) to a high of $7.8865 (Dec 13, 2023), with a median of $3.6322 per EA.
Are there cheaper alternatives to DICLOFENAC POTASSIUM 25 MG CAP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DICLOFENAC POTASSIUM 25 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DICLOFENAC POTASSIUM 25 MG CAP?
DICLOFENAC POTASSIUM 25 MG CAP (NDC 00480943589) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.